Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ben McMillan, CIO of IDX Digital Assets,
Recent Videos
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper
Suggestions
00:10:00
Introduction to Social Enterprise: Legal Structures and Funding Strategies
00:10:00
David Schwimmer: Steering the London Stock Exchange Group Towards Global Financial Leadership
00:10:00
complete generalists we invest in phenomenal people|Brian Stafford,Partner,Blue Collective
00:10:00
Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group
00:10:00
Positive Trends in China Internet Sector: Travel, E-Commerce, and Cloud Computing
00:00:00
Corline Biomedical at Pareto Securities' Health Care Conference - Henrik Nittmar , CEO, Corline Biomedical
00:10:00
AI Safety in Fintech: Insights from Joseph Kamyar and Nicola Kerr-Shaw | John Slate - Founder of Skadden
00:10:00
The Relationship Between CDS, Bonds, and Equity Pricing
00:10:00
Smart Money: Funding and Exit Trends|Anna Fang,investor,ZhenFund
00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:10:00
Apollo's growth strategy, his views on alternative investments, and why he believes alts could soon make up 50 percent of individuals' portfolios|Marc Rowan, CEO and Co-Founder of Apollo Global Management
00:10:00
Interview with manager of Alfred Berg Gambak, Petter Tusvik | Tomas Scherp, CEO, Alfred Berg Kapitalforvaltning ASAS OF 29 FEB 2024